CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.
Vigano
A
A
Chair of Pediatrics IV, Milano University, Ospedale Luigi Sacco, Italy.
Saresella
M
M
Villa
M L
ML
Ferrante
P
P
Clerici
M
M
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D019380:Anti-HIV Agents / Q000627:therapeutic use; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000097:blood*; D015415:Biomarkers; D016827:CD8 Antigens / Q000097:blood*; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D008562:Membrane Glycoproteins; D009097:Multienzyme Complexes / Q000097:blood*; D009244:NAD+ Nucleosidase / Q000097:blood*; D011379:Prognosis; D013601:T-Lymphocytes / Q000737:chemistry*
D019380:Anti-HIV Agents; D015703:Antigens, CD; D000943:Antigens, Differentiation; D015415:Biomarkers; D016827:CD8 Antigens; D008562:Membrane Glycoproteins; D009097:Multienzyme Complexes; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1